With new therapies that promise to slow Alzheimer’s disease
WEBJul 16, 2023 — Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
House Passes Bipartisan Legislation in Fight to End Alzheimer's
WEB2 days ago — House Passes Critical Bipartisan Legislation to Build on Progress in the Fight Against Alzheimer’s. — NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act head to White House to be signed into law —. Washington, D.C., September 23, 2024 — Today the U.S. House of Representatives unanimously passed critical ...
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 — The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
First Alzheimer’s drug to slow disease progression gets full FDA ...
WEBJul 7, 2023 — CNN — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 — The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
WEBJul 28, 2024 — A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds - The New York Times. It was much more accurate than primary care doctors using cognitive tests and CT...
New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 — PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Study Suggests Genetics as a Cause, Not Just a Risk, for Some …
WEBMay 6, 2024 — People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before...
FDA approves new Alzheimer’s drug that appears to slow disease
WEBJan 6, 2023 — The Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness.
Lilly's Alzheimer’s drug that can slow disease gets ... - NBC News
WEBJun 10, 2024 — By The Associated Press. A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for...